These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 24034645

  • 21. Immune complex and complement-mediated leukocyte recruitment in bullous pemphigoid.
    Gammon WR.
    Immunol Ser; 1989; 46():509-25. PubMed ID: 2488868
    [No Abstract] [Full Text] [Related]

  • 22. Bullous pemphigoid and other basement membrane antigens.
    Diaz LA, Anhalt GJ.
    Clin Dermatol; 1987; 5(1):93-109. PubMed ID: 3552197
    [No Abstract] [Full Text] [Related]

  • 23. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
    Sitaru C, Schmidt E, Petermann S, Munteanu LS, Bröcker EB, Zillikens D.
    J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
    [Abstract] [Full Text] [Related]

  • 24. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
    Domloge-Hultsch N, Utecht L, James W, Yancey KB.
    Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
    [Abstract] [Full Text] [Related]

  • 25. [Paraneoplastic pemphigus. Induction of autoantibodies against structural proteins in the skin].
    Zillikens D, Bröcker EB.
    Hautarzt; 1994 Dec; 45(12):827-33. PubMed ID: 7843961
    [Abstract] [Full Text] [Related]

  • 26. Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece.
    Patsatsi A, Vyzantiadis TA, Devliotou-Panagiotidou D, Chrysomallis F, Sotiriadis D.
    Clin Exp Dermatol; 2008 Mar; 33(2):183-5. PubMed ID: 18093242
    [Abstract] [Full Text] [Related]

  • 27. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L, Deidda S, Aste N.
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [Abstract] [Full Text] [Related]

  • 28. Pemphigoid gestationis with autoantibodies exclusively directed to the 230-kDa bullous pemphigoid antigen (BP230Ag).
    Ghohestani R, Nicolas JF, Kanitakis J, Bedane C, Faure M, Claudy A.
    Br J Dermatol; 1996 Mar; 134(3):603-4. PubMed ID: 8731696
    [No Abstract] [Full Text] [Related]

  • 29. Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values.
    Andreadis D, Lorenzini G, Drakoulakos D, Belazi M, Mihailidou E, Velkos G, Mourellou-Tsatsou O, Antoniades D.
    Eur J Oral Sci; 2006 Oct; 114(5):374-80. PubMed ID: 17026501
    [Abstract] [Full Text] [Related]

  • 30. Serological studies in bullous pemphigoid: a literature review of antibody titers at presentation and in clinical remission.
    Leuci S, Gürcan HM, Ahmed AR.
    Acta Derm Venereol; 2010 Mar; 90(2):115-21. PubMed ID: 20169293
    [Abstract] [Full Text] [Related]

  • 31. [Anti-desmoglein 1 and 3 antibody, anti-BP180(NC16a) antibody, anti-BP230 antibody].
    Amagai M.
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():614-7. PubMed ID: 20942145
    [No Abstract] [Full Text] [Related]

  • 32. The hemidesmosome: a target in auto-immune bullous disease.
    Eady RA.
    Dermatology; 1994 Jun; 189 Suppl 1():38-41. PubMed ID: 8049561
    [Abstract] [Full Text] [Related]

  • 33. Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes.
    Westgate GE, Weaver AC, Couchman JR.
    J Invest Dermatol; 1985 Mar; 84(3):218-24. PubMed ID: 2579167
    [Abstract] [Full Text] [Related]

  • 34. Lichenoid erythrodermic bullous pemphigoid of the African patient.
    Joly P, Tanasescu S, Wolkenstein P, Bocquet H, Gilbert D, Thomine E, Wechsler J, Roujeau JC, Revuz J, Tron F, Lauret P.
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):691-7. PubMed ID: 9810884
    [Abstract] [Full Text] [Related]

  • 35. Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions.
    Hara H, Makino T, Matsui K, Takegami Y, Koga H, Fukuda S, Ishii N, Hashimoto T, Shimizu T.
    Eur J Dermatol; 2014 Nov; 24(4):488-9. PubMed ID: 25178966
    [No Abstract] [Full Text] [Related]

  • 36. Rat bladder epithelium: a sensitive substrate for indirect immunofluorescence of bullous pemphigoid.
    Delmonte S, Cozzani E, Drosera M, Parodi A, Rebora A.
    Acta Derm Venereol; 2000 May; 80(3):175-8. PubMed ID: 10954206
    [Abstract] [Full Text] [Related]

  • 37. Vesicular pemphigoid with circulating autoantibodies against 230-kDa and 180-kDa proteins, and additional autoantibodies against 97-kDa and 45-kDa proteins.
    Lai FJ, Sheu HM, Lee JY, Cheng CL, Chen W.
    Int J Dermatol; 2007 Feb; 46(2):206-9. PubMed ID: 17269979
    [Abstract] [Full Text] [Related]

  • 38. Clinical and immunological factors associated with bullous pemphigoid relapse.
    Fine JD.
    JAMA Dermatol; 2014 Jan; 150(1):34. PubMed ID: 24226151
    [No Abstract] [Full Text] [Related]

  • 39. Smaller desmosomes are seen in the skin of pemphigus patients with anti-desmoglein 1 antibodies but not in patients with anti-desmoglein 3 antibodies.
    van der Wier G, Pas HH, Kramer D, Diercks GFH, Jonkman MF.
    J Invest Dermatol; 2014 Aug; 134(8):2287-2290. PubMed ID: 24621791
    [No Abstract] [Full Text] [Related]

  • 40. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
    Feldrihan V, Licarete E, Florea F, Cristea V, Popescu O, Sitaru C, Chiriac MT.
    Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.